n-methyladenosine has been researched along with Adenocarcinoma of Lung in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 17 (94.44) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Wang, C; Xiong, Y; Yang, X; Zhang, D; Zhang, R | 1 |
| Guo, M; Li, Z; Ming, L; Qin, Z; Wan, J; Wang, Y; Yang, Z; Zhao, Z; Zheng, J | 1 |
| Bai, Z; Wu, X | 1 |
| Bao, F; Chu, X; Feng, L; Sun, Z; Wang, W | 1 |
| Chen, B; Hu, Z; Zhang, Y; Zhu, L | 1 |
| Ding, H; Gao, C; Kong, N; Li, J; Sun, Z; Tang, T; Wu, L; Xu, M; Zhang, F | 1 |
| Huang, T; Ye, W | 1 |
| Bai, L; Chen, Q; Hu, CP; Jiang, J; Li, YY; Wan, RJ; Zhang, Y; Zhao, BR | 1 |
| Huang, Y; Ma, M; Wang, B; Wang, W; Yang, Y; Ye, L; Zhao, G | 1 |
| Ge, H; Jin, L; Wang, N; Wang, X; Wang, Y; Wu, S; Xu, Y; Zhao, J; Zhou, F | 1 |
| Chao, Y; Ji, W; Shang, J | 1 |
| Hu, Q; Li, J; Liu, L; Liu, X; Sun, R; Zhang, Y | 1 |
| Hu, D; Wang, M; Zhu, J | 1 |
| Xie, Y; Zhao, W | 1 |
| Feng, F; Gao, C; Li, H; Liu, C; Liu, L; Sun, C; Zhou, C; Zhuang, J | 1 |
| Chang, N; Che, Y; Jiang, J; Qiao, T; Wu, B; Wu, Y; Xiong, J; Xu, L; Zhang, J; Zhang, X; Zhang, Y; Zhou, Y | 1 |
| Huang, Z; Shi, J; Shi, M; Wang, J; Zhang, H; Zheng, M; Zhou, H; Zhou, Y | 1 |
| Ahmed, M; Gao, S; Guan, J; Guo, H; He, HH; Hua, JT; Moran, MF; Soares, F; Tsao, MS; Wang, M; Wang, S; Zeng, Y | 1 |
1 trial(s) available for n-methyladenosine and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Topics: Adenocarcinoma of Lung; Adenosine; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nomograms; Risk Assessment; RNA, Long Noncoding | 2022 |
17 other study(ies) available for n-methyladenosine and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Lung Neoplasms; Methyltransferases; Prognosis | 2022 |
N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Computational Biology; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Long Noncoding; Transcriptome; Tumor Microenvironment | 2021 |
Multi-omics analysis of m
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Biomarkers, Tumor; CTLA-4 Antigen; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Prognosis; Tumor Microenvironment | 2021 |
An N
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms | 2022 |
N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Proliferation; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Methyltransferases; Microfilament Proteins; RNA Stability; RNA, Antisense; RNA, Long Noncoding; Tumor Cells, Cultured | 2022 |
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Methylation; RNA; RNA Processing, Post-Transcriptional; Tumor Microenvironment | 2022 |
N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Tumor Microenvironment | 2022 |
The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Humans; Lung Neoplasms; Mammals; Prognosis; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering | 2022 |
Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antigens, CD; Humans; Lung Neoplasms; Lymphocyte Activation Gene 3 Protein; Prognosis; RNA-Binding Proteins; Tumor Microenvironment; Ubiquitin-Protein Ligases | 2022 |
ALKBH5-m
Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Proliferation; Forkhead Box Protein M1; Humans; Hypoxia; Lung Neoplasms; Mice; Neoplasm Invasiveness; Signal Transduction | 2020 |
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Cohort Studies; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Prognosis; RNA, Messenger | 2020 |
Deciphering N
Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Biomarkers, Tumor; Disease-Free Survival; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Kaplan-Meier Estimate; Male; Methyltransferases; Multivariate Analysis; Neoplasm Staging; Prognosis; RNA Helicases; RNA-Binding Proteins; RNA-Seq; Transcriptome | 2020 |
KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Movement; Cell Proliferation; Databases, Genetic; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methylation; Middle Aged; Mucin-3; Neoplasm Invasiveness; Neoplasm Staging; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Signal Transduction; Tumor Burden | 2021 |
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Topics: Adenocarcinoma of Lung; Adenosine; Databases, Genetic; DNA Copy Number Variations; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Risk Assessment; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome | 2021 |
METTL3-mediated m
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; F-Box-WD Repeat-Containing Protein 7; Heterografts; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger | 2021 |
Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Prognosis; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome; Tumor Microenvironment | 2021 |
Refined RIP-seq protocol for epitranscriptome analysis with low input materials.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Antibodies; Base Sequence; Gene Expression Profiling; Humans; Immunoprecipitation; RNA | 2018 |